Skip to content
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — Maj 2024

Genmab — Maj 2024

Planlagt Fastgjort Låst Flyttet Genmab
540 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • E Offline
    E Offline
    E_L
    wrote on sidst redigeret af
    #104

    Rome lung cancer summit
    https://twitter.com/StephenVLiu/status/1787396191535112279/photo/2

    1 Reply Last reply
    0
    • V Offline
      V Offline
      Vitus
      wrote on sidst redigeret af
      #105

      Tager den for længe siden….

      1 Reply Last reply
      0
      • L Offline
        L Offline
        lahn1
        wrote on sidst redigeret af
        #106

        What are they saying EL ?

        1 Reply Last reply
        0
        • E Offline
          E Offline
          E_L
          wrote on sidst redigeret af
          #107

          he mentions acasunlimab / GEN1046
          but most of the other drugs he mentions on that slide have discontinued development; showing what a difficult area it is to succeed.

          1 Reply Last reply
          0
          • E Offline
            E Offline
            E_L
            wrote on sidst redigeret af
            #108

            here tisotumab mentioned as NSCLC drug, doubt it , but who knows
            https://twitter.com/StephenVLiu/status/1787419518131654815/photo/2

            1 Reply Last reply
            0
            • G Offline
              G Offline
              GeorgeBest
              wrote on sidst redigeret af
              #109

              Hvis I har en LinkedIn profil, vil jeg anbefale at følge Claus Johansen. Han har mange gode indlæg om sundhedsaktier, deriblandt Genmab

              1 Reply Last reply
              0
              • E Offline
                E Offline
                E_L
                wrote on sidst redigeret af
                #110

                https://investors.biontech.de/static-files/c8ca4858-2a59-45ab-bc43-6b1df6e3e784 biontech Q1 '24 presentation

                1 Reply Last reply
                0
                • SolsenS Offline
                  SolsenS Offline
                  Solsen
                  wrote on sidst redigeret af
                  #111

                  5 fællesprogrammer/-stoffer med Genmab. Imponerende og se deres optag af pts i forsøg. Det er nu Biontech ruller deres forsøg ud,

                  1 Reply Last reply
                  0
                  • L Offline
                    L Offline
                    lahn1
                    wrote on sidst redigeret af
                    #112

                    Thx EL do we expect NSCLC data this side of summer ?

                    1 Reply Last reply
                    0
                    • E Offline
                      E Offline
                      E_L
                      wrote on sidst redigeret af
                      #113

                      I doubt that, we will get cervical & head and neck cancer at ASCO though. head and neck should be the next area to go into; they said they will speak with regulators about the next steps for that

                      1 Reply Last reply
                      0
                      • E Offline
                        E Offline
                        E_L
                        wrote on sidst redigeret af
                        #114

                        i would be surprised to see them go further with NSCLC, there is so much competition there... but i don't mind being surprised 😉 I would have expected ovarian cancer to be more logical

                        1 Reply Last reply
                        0
                        • SolsenS Offline
                          SolsenS Offline
                          Solsen
                          wrote on sidst redigeret af
                          #115

                          If they se a chance they will persue it. Huge market.

                          1 Reply Last reply
                          0
                          • P Offline
                            P Offline
                            ProinvestorNEWS
                            wrote on sidst redigeret af
                            #116

                            Transactions in Connection with Share Buy-back Program https://www.proinvestor.com/investornyt/1155522/transactions-in-connection-with-share-buy-back-program

                            1 Reply Last reply
                            0
                            • E Offline
                              E Offline
                              E_L
                              wrote on sidst redigeret af
                              #117

                              BioNTech Se (BNTX) Q1 2024 Earnings Call Transcript https://www.fool.com/earnings/call-transcripts/2024/05/06/biontech-se-bntx-q1-2024-earnings-call-transcript/

                              1 Reply Last reply
                              0
                              • E Offline
                                E Offline
                                E_L
                                wrote on sidst redigeret af
                                #118

                                morningstar - Genmab’s results are tracking our expectations, and we maintain our fair value estimate of DKK 2,650 per share. https://www.morningstar.com/stocks/xcse/gmab/quote

                                1 Reply Last reply
                                0
                                • V Offline
                                  V Offline
                                  Vitus
                                  wrote on sidst redigeret af
                                  #119

                                  Genmab aktien har ikke specielt svært ved at droppe under kurs 2000 😞

                                  1 Reply Last reply
                                  0
                                  • P Offline
                                    P Offline
                                    Pensionisten
                                    wrote on sidst redigeret af
                                    #120

                                    Ja, det er p.t. lidt svært at se lyspunkterne i Genmab aktien. Lide

                                    1 Reply Last reply
                                    0
                                    • P Offline
                                      P Offline
                                      Pensionisten
                                      wrote on sidst redigeret af
                                      #121

                                      Lidt : Dead man walking...

                                      1 Reply Last reply
                                      0
                                      • P Offline
                                        P Offline
                                        ProinvestorNEWS
                                        wrote on sidst redigeret af
                                        #122

                                        Kort ugevideo: Speedsnak om Genmab, Gubra, Zealand Pharma, Bakkafrost, Avance Gas, BW-LPG m.fl https://www.proinvestor.com/boards/120315

                                        1 Reply Last reply
                                        0
                                        • BulderB Offline
                                          BulderB Offline
                                          Bulder
                                          wrote on sidst redigeret af
                                          #123

                                          Mim8 https://borsen.dk/nyheder/virksomheder/novo-chef-om-stillestaaende-division-nyt-om-faa-uger?b_source=seneste-nyt\&b_medium=row_1\&b_campaign=list_21

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper